DealMaker congratulates Monogram Orthopaedics Inc., (NASDAQ:MGRM) on listing on the Nasdaq Stock Market on May 18, 2023. Monogram is a medical technology company focused on reconstructive joint procedures and orthopedic implants. The company has a long-standing relationship with DealMaker and has raised over $44 million through online capital formation, including a significant amount under Regulation A.
“It's incredible to see how Monogram harnessed the power of online capital formation to create a hugely supportive community of shareholders,” said Mat Goldstein, Co-Founder of DealMaker. “That community has powered Monogram’s capital markets strategy, from the seed stage through this public listing on NASDAQ.”
The Monogram Orthopaedics listing is a significant milestone for equity crowdfunding and one of a handful of examples of issuers that start with online capital raising and move to a national stock exchange.
“Many institutional investors and firms are reluctant to enter into the equity crowdfunding space and often assume there is no path to liquidity,” said Rebecca Kacaba, DealMaker Co-Founder and CEO. “We’ve seen issuers adopt another path to raising capital: Reg CF to Reg A then Reg A to public listing. It’s a great supplement to the traditional capital markets process.”
Monogram has been an eye-catching story in the equity crowdfunding space. Monogram made history by completing the first fully-remote robotic orthopedic surgery in March 2023. In a live telecast, the Austin-based robot was controlled from New York City in real-time via an advanced user-operated foot pedal.
“This was an incredible achievement for orthopedic robotics and medicine,” said founder Dr. Douglas Unis. “Despite being over 1,700 miles away, the real-time system was highly responsive with minimal latency. The applications for a robust system with these capabilities are tremendous. No system on the market today is capable of doing what Monogram just demonstrated.”
DealMakeris on a mission to bring online capital formation into the mainstream. DealMaker offers a suite of primary issuance, shareholder management, and capital raising solutions that includes equity crowdfunding, investor ranking algorithms, and data/analytical tools to support all capital raise types and all securities. DealMaker’s innovative technology was designed to enable organizations to own and control exempt market raises to get the money they need, faster. DealMaker works for their issuers: putting brands and founders back in control to run streamlined, successful capital raises. The company’s offices are located in Toronto, Canada, Austin, Texas and Tampa, Florida. Visit DealMaker.tech for more information.